CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- 8-K Event Other events
- 4 Open-market buy Chief Executive Officer bought 35,000 shares at $1.70 ($59,500)
- 4 Open-market buy Director bought 1,000 shares at $1.91 ($1,910)
- 8-K Event New debt or obligation · Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 107,000 shares (grant or award)
- 4 Grant or award President and COO acquired 69,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 55,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 79,000 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Results of operations · Other events
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
Page 11 of 49 · 978 filings